PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9756504-7	1998	A single injection of TTX, atropine, or hexamethonium reduced the luminal release of 5-HT, whereas a single injection of VIP-(10-28) stimulated the luminal release of 5-HT and this effect was antagonized by atropine, hexamethonium, or TTX.	Hexamethonium	217-230	vasoactive intestinal peptide	Rattus norvegicus	121-124	
6136311-5	1983	A simultaneous perfusion of hexamethonium (1.9 x 10(-4) M/min) blocked ACh-induced VIP release.	Hexamethonium	28-41	vasoactive intestinal peptide	Rattus norvegicus	83-86	
7924732-6	1994	The HCO3- secretion during a single intravenous infusion of VIP (12 nmol/kg/hr), 13.9 +/- 4.2 mumol/cm/hr, was unchanged by atropine, reduced to 10.0 +/- 3.5 mumol/cm/hr by hexamethonium, and augmented to 18.9 +/- 4.7 mumol/cm/hr by indomethacin.	Hexamethonium	173-186	vasoactive intestinal peptide	Rattus norvegicus	60-63	
7602539-12	1995	Hexamethonium abolished vagal-stimulated NO production and VIP release.	Hexamethonium	0-13	vasoactive intestinal peptide	Rattus norvegicus	59-62	
7924732-8	1994	HCl-induced increases in luminal outputs of VIP, substance P, and neurokinin A (the two latter with unknown roles) were differentially affected by atropine, hexamethonium, and indomethacin, indicating that the acid challenge released the peptides through controlled mechanisms.	Hexamethonium	157-170	vasoactive intestinal peptide	Rattus norvegicus	44-47